Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Is MK-677 Legal 2026 Status — Comparison

Institutional research (universities, labs) Lawful if documented FDA 505(i) exemption for IND compounds Low. Legitimate research protected None if protocols followed Individual "research use" (consumers) Technically prohibited FD&C Act 505(a). Unapproved drug

This comparison does not assign a generated winner or score.

  • Institutional research (universities, labs)
  • Lawful if documented
  • FDA 505(i) exemption for IND compounds
  • Low. Legitimate research protected
  • None if protocols followed
  • Individual "research use" (consumers)
  • Technically prohibited
  • FD&C Act 505(a). Unapproved drug for human use
  • Medium. Rarely prosecuted individually
  • Low (targets vendors instead)
  • Supplement or performance use (marketed for consumption)
  • Illegal
  • FDA enforcement via warning letters, injunctions
  • High. Violates unapproved drug provision
  • Active. FDA issued 12+ letters in 2025
  • Athletic use (WADA-tested athletes)
  • Prohibited substance
  • WADA Prohibited List S2
  • Severe. 4-year ban minimum
  • High. Routine testing detects use
  • Veterinary research
  • Lawful under veterinary IND
  • FDA CVM oversight
  • Low. Documented vet studies allowed
  • None if proper protocols
  • International purchase/import
  • Variable by jurisdiction
  • Customs enforcement + destination country law
  • High. Seizure risk at border
  • Medium. Depends on quantity and labeling
More references

Related material